Yonathan Lissanu

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib”.

3-Phosphoinositide-dependent kinase 1 drives acquired resistance to osimertinib

Communications Biology(2023)10.1038/s42003-023-04889-w

N/A

0DataRank · unranked

11 citations

Mourad Majidi, Bingliang Fang, Feng Meng, Lihui Gao, Ruping Shao +16 more

Enhancer reprogramming underlies therapeutic utility of a SMARCA2 degrader in SMARCA4 mutant cancer

Cell chemical biology(2024)10.1016/j.chembiol.2024.09.004

N/A

0DataRank · unranked

17 citations

Nicholas Blazanin, Yuanxin Xi, Yanyan Han, Md Qudratullah, Xiaobing Liang +8 more

Therapeutic modulation of ROCK overcomes metabolic adaptation of cancer cells to OXPHOS inhibition and drives synergistic anti-tumor activity

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.16.613317

N/A

0DataRank · unranked

4 citations

Xiaobing Liang, Iqbal Mahmud, Eiru Kim, Sara Martı́nez-Martı́nez, Lin Tan +10 more